The Food and Drug Administration (FDA) on Saturday announced that it had issued an emergency use authorization for an at-home coronavirus sample collection kit. The kit allows consumers to self-collect a nasal sample and then send it off to be tested for the novel coronavirus, which causes the disease covid-19.
More Stories
Despite promises of solidarity on Covid-19, rich countries are snapping up the supply of promising vaccines
Historic U.S. COVID vaccine campaign launches with convoy of trucks
Brazil rolls out COVID-19 vaccination plan